Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage

Vestal, ML; Hodulik, K; Mando-Vandrick, J; James, ML; Ortel, TL; Fuller, M; Notini, M; Friedland, M; Welsby, IJ

Vestal, ML (通讯作者)，Duke Univ, Med Ctr, Dept Pharm, Durham, NC 27710 USA.;Vestal, ML (通讯作者)，Duke Reg Hosp, Dept Pharm, 3643 North Roxboro St, Durham, NC 27704 USA.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1): 167

Abstract

Limited data exists regarding the clinical outcomes of andexanet alfa and four factor prothrombin complex concentrate (4F-PCC) for reversal of apixaba......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索